Challenges and approaches in the diagnosis and differential diagnosis of atypical <scp>CLL</scp> : A response to ‘Defining atypical <scp>CLL</scp> for reproducible diagnosis: Implications of the work by Wang et al.’
Year: 2025
Type: letter
Language: en
Topic: Chronic Lymphocytic Leukemia Research
Authors and affiliations:
raw_author_name: Wei J. Wang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Wei J. Wang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Sa A. Wang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Hong Fang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Qing Wei
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Jeffrey L. Jorgensen
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Shimin Hu
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Jie Xu
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Shaoying Li
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA
raw_author_name: Guilin Tang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: Zhenya Tang
raw_affiliation_strings: Department of Pathology, Microbiology and Immunology University of Nebraska Medical Center  Omaha Nebraska USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
raw_author_name: L. Jeffrey Medeiros
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
raw_author_name: Wei Wang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA
raw_author_name: Wei Wang
raw_affiliation_strings: Department of Hematopathology The University of Texas MD Anderson Cancer Center  Houston Texas USA